Cargando…

Dairy and cardiovascular health: Friend or foe?

Cardiovascular disease (CVD) prevalence at a global level is predicted to increase substantially over the next decade due to the increasing ageing population and incidence of obesity. Hence, there is an urgent requirement to focus on modifiable contributors to CVD risk, including a high dietary inta...

Descripción completa

Detalles Bibliográficos
Autores principales: Markey, O, Vasilopoulou, D, Givens, D I, Lovegrove, J A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207191/
https://www.ncbi.nlm.nih.gov/pubmed/25400508
http://dx.doi.org/10.1111/nbu.12086
_version_ 1782340934348832768
author Markey, O
Vasilopoulou, D
Givens, D I
Lovegrove, J A
author_facet Markey, O
Vasilopoulou, D
Givens, D I
Lovegrove, J A
author_sort Markey, O
collection PubMed
description Cardiovascular disease (CVD) prevalence at a global level is predicted to increase substantially over the next decade due to the increasing ageing population and incidence of obesity. Hence, there is an urgent requirement to focus on modifiable contributors to CVD risk, including a high dietary intake of saturated fatty acids (SFA). As an important source of SFA in the UK diet, milk and dairy products are often targeted for SFA reduction. The current paper acknowledges that milk is a complex food and that simply focusing on the link between SFA and CVD risk overlooks the other beneficial nutrients of dairy foods. The body of existing prospective evidence exploring the impact of milk and dairy consumption on risk factors for CVD is reviewed. The current paper highlights that high milk consumption may be beneficial to cardiovascular health, while illustrating that the evidence is less clear for cheese and butter intake. The option of manipulating the fatty acid profile of ruminant milk is discussed as a potential dietary strategy for lowering SFA intake at a population level. The review highlights that there is a necessity to perform more well-controlled human intervention-based research that provides a more holistic evaluation of fat-reduced and fat-modified dairy consumption on CVD risk factors including vascular function, arterial stiffness, postprandial lipaemia and markers of inflammation. Additionally, further research is required to investigate the impact of different dairy products and the effect of the specific food matrix on CVD development.
format Online
Article
Text
id pubmed-4207191
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42071912014-11-13 Dairy and cardiovascular health: Friend or foe? Markey, O Vasilopoulou, D Givens, D I Lovegrove, J A Nutr Bull Original Articles Cardiovascular disease (CVD) prevalence at a global level is predicted to increase substantially over the next decade due to the increasing ageing population and incidence of obesity. Hence, there is an urgent requirement to focus on modifiable contributors to CVD risk, including a high dietary intake of saturated fatty acids (SFA). As an important source of SFA in the UK diet, milk and dairy products are often targeted for SFA reduction. The current paper acknowledges that milk is a complex food and that simply focusing on the link between SFA and CVD risk overlooks the other beneficial nutrients of dairy foods. The body of existing prospective evidence exploring the impact of milk and dairy consumption on risk factors for CVD is reviewed. The current paper highlights that high milk consumption may be beneficial to cardiovascular health, while illustrating that the evidence is less clear for cheese and butter intake. The option of manipulating the fatty acid profile of ruminant milk is discussed as a potential dietary strategy for lowering SFA intake at a population level. The review highlights that there is a necessity to perform more well-controlled human intervention-based research that provides a more holistic evaluation of fat-reduced and fat-modified dairy consumption on CVD risk factors including vascular function, arterial stiffness, postprandial lipaemia and markers of inflammation. Additionally, further research is required to investigate the impact of different dairy products and the effect of the specific food matrix on CVD development. Blackwell Publishing Ltd 2014-06 2014-05-19 /pmc/articles/PMC4207191/ /pubmed/25400508 http://dx.doi.org/10.1111/nbu.12086 Text en © 2014 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Markey, O
Vasilopoulou, D
Givens, D I
Lovegrove, J A
Dairy and cardiovascular health: Friend or foe?
title Dairy and cardiovascular health: Friend or foe?
title_full Dairy and cardiovascular health: Friend or foe?
title_fullStr Dairy and cardiovascular health: Friend or foe?
title_full_unstemmed Dairy and cardiovascular health: Friend or foe?
title_short Dairy and cardiovascular health: Friend or foe?
title_sort dairy and cardiovascular health: friend or foe?
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207191/
https://www.ncbi.nlm.nih.gov/pubmed/25400508
http://dx.doi.org/10.1111/nbu.12086
work_keys_str_mv AT markeyo dairyandcardiovascularhealthfriendorfoe
AT vasilopouloud dairyandcardiovascularhealthfriendorfoe
AT givensdi dairyandcardiovascularhealthfriendorfoe
AT lovegroveja dairyandcardiovascularhealthfriendorfoe